Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-324447
Filing Date
2026-07-29
Accepted
2026-07-29 20:06:43
Documents
1
Period of Report
2026-07-28

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 6047
  Complete submission text file 0001193125-26-324447.txt   7484
Mailing Address C/O SANGAMO BIOSCIENCES, INC STE-A-100 POINT RICHMOND TECH, 501 CANAL BLVD, RICHMOND CA 94804
Business Address
ZANTE GREG (Reporting) CIK: 0001264949 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37355 | Film No.: 261219747

Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 500 SAN DIEGO CA
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 500 SAN DIEGO CA 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)